Direct reprogramming of fibroblasts into myocytes to reverse fibrosis

Naoto Muraoka, Masaki Ieda

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Heart disease is a major cause of morbidity and mortality worldwide. The low regenerative capacity of adult human hearts has thus far limited the available therapeutic approaches for heart failure. Therefore, new therapies that can regenerate damaged myocardium and improve heart function are urgently needed. Although cell transplantation-based therapies may hold great potential, direct reprogramming of endogenous cardiac fibroblasts, which represent more than half of the cells in the heart, into functional cardiomyocytes in situ may be an alternative strategy by which to regenerate the heart. We and others demonstrated that functional cardiomyocytes can be directly generated from fibroblasts by using several combinations of cardiac-enriched factors in mouse and human. In vivo gene delivery of cardiac reprogramming factors generates new cardiac muscle and improved heart function after myocardial infarction in mouse. This article reviews recent progress in cardiac reprogramming research and discusses the perspectives and challenges of this new technology for future regenerative therapy. ©

Original languageEnglish
Pages (from-to)21-37
Number of pages17
JournalAnnual Review of Physiology
Volume76
DOIs
Publication statusPublished - 2014 Feb

Fingerprint

Muscle Cells
Fibrosis
Fibroblasts
Cardiac Myocytes
Myocardium
Cell Transplantation
Therapeutics
Heart Diseases
Heart Failure
Myocardial Infarction
Technology
Morbidity
Mortality
Research
Genes

Keywords

  • Cardiac regeneration
  • Heart
  • Heart failure
  • Induced cardiomyocytes
  • Stem cell

ASJC Scopus subject areas

  • Physiology

Cite this

Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. / Muraoka, Naoto; Ieda, Masaki.

In: Annual Review of Physiology, Vol. 76, 02.2014, p. 21-37.

Research output: Contribution to journalArticle

Muraoka, Naoto ; Ieda, Masaki. / Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. In: Annual Review of Physiology. 2014 ; Vol. 76. pp. 21-37.
@article{0f5e0ef60db84570962013ec9908baa8,
title = "Direct reprogramming of fibroblasts into myocytes to reverse fibrosis",
abstract = "Heart disease is a major cause of morbidity and mortality worldwide. The low regenerative capacity of adult human hearts has thus far limited the available therapeutic approaches for heart failure. Therefore, new therapies that can regenerate damaged myocardium and improve heart function are urgently needed. Although cell transplantation-based therapies may hold great potential, direct reprogramming of endogenous cardiac fibroblasts, which represent more than half of the cells in the heart, into functional cardiomyocytes in situ may be an alternative strategy by which to regenerate the heart. We and others demonstrated that functional cardiomyocytes can be directly generated from fibroblasts by using several combinations of cardiac-enriched factors in mouse and human. In vivo gene delivery of cardiac reprogramming factors generates new cardiac muscle and improved heart function after myocardial infarction in mouse. This article reviews recent progress in cardiac reprogramming research and discusses the perspectives and challenges of this new technology for future regenerative therapy. {\circledC}",
keywords = "Cardiac regeneration, Heart, Heart failure, Induced cardiomyocytes, Stem cell",
author = "Naoto Muraoka and Masaki Ieda",
year = "2014",
month = "2",
doi = "10.1146/annurev-physiol-021113-170301",
language = "English",
volume = "76",
pages = "21--37",
journal = "Annual Review of Physiology",
issn = "0066-4278",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Direct reprogramming of fibroblasts into myocytes to reverse fibrosis

AU - Muraoka, Naoto

AU - Ieda, Masaki

PY - 2014/2

Y1 - 2014/2

N2 - Heart disease is a major cause of morbidity and mortality worldwide. The low regenerative capacity of adult human hearts has thus far limited the available therapeutic approaches for heart failure. Therefore, new therapies that can regenerate damaged myocardium and improve heart function are urgently needed. Although cell transplantation-based therapies may hold great potential, direct reprogramming of endogenous cardiac fibroblasts, which represent more than half of the cells in the heart, into functional cardiomyocytes in situ may be an alternative strategy by which to regenerate the heart. We and others demonstrated that functional cardiomyocytes can be directly generated from fibroblasts by using several combinations of cardiac-enriched factors in mouse and human. In vivo gene delivery of cardiac reprogramming factors generates new cardiac muscle and improved heart function after myocardial infarction in mouse. This article reviews recent progress in cardiac reprogramming research and discusses the perspectives and challenges of this new technology for future regenerative therapy. ©

AB - Heart disease is a major cause of morbidity and mortality worldwide. The low regenerative capacity of adult human hearts has thus far limited the available therapeutic approaches for heart failure. Therefore, new therapies that can regenerate damaged myocardium and improve heart function are urgently needed. Although cell transplantation-based therapies may hold great potential, direct reprogramming of endogenous cardiac fibroblasts, which represent more than half of the cells in the heart, into functional cardiomyocytes in situ may be an alternative strategy by which to regenerate the heart. We and others demonstrated that functional cardiomyocytes can be directly generated from fibroblasts by using several combinations of cardiac-enriched factors in mouse and human. In vivo gene delivery of cardiac reprogramming factors generates new cardiac muscle and improved heart function after myocardial infarction in mouse. This article reviews recent progress in cardiac reprogramming research and discusses the perspectives and challenges of this new technology for future regenerative therapy. ©

KW - Cardiac regeneration

KW - Heart

KW - Heart failure

KW - Induced cardiomyocytes

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84894144934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894144934&partnerID=8YFLogxK

U2 - 10.1146/annurev-physiol-021113-170301

DO - 10.1146/annurev-physiol-021113-170301

M3 - Article

C2 - 24079415

AN - SCOPUS:84894144934

VL - 76

SP - 21

EP - 37

JO - Annual Review of Physiology

JF - Annual Review of Physiology

SN - 0066-4278

ER -